1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Brain cancers

Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]

In development [GID-TA11498] Expected publication date: 10 September 2025

  • Project information
  • Project documents

NIHRIO BN: 28716-Vorasidenib-for-Glioma-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)